Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F Ambinder

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
JCO Oncology Practice|March 6, 2020
A Tale of Two UrinesArjun Gupta, Richard F Ambinder
The Journal of Infectious Diseases|October 6, 2005
Mononucleosis in the laboratoryRichard F Ambinder, Lan Lin
Current Opinion in Oncology|August 23, 2002
Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirusHetty Carraway, Richard F Ambinder
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2018
Resistance Is Futile: Engineering the Adoptive T-Cell Therapies of the FutureEugene Shenderov, Richard F Ambinder
Current Treatment Options in Oncology|April 4, 2013
EBV-related lymphomas: new approaches to treatmentJennifer A Kanakry, Richard F Ambinder
Critical Reviews in Oncology/Hematology|November 21, 2007
Immunotherapies for Hodgkin's lymphomaYvette L Kasamon, Richard F Ambinder
Blood|June 4, 2011
When differentiation goes viralCourtney M Shirley, Richard F Ambinder
Blood|February 8, 2014
Old variables, new value: a refined IPI for DLBCLJennifer A Kanakry, Richard F Ambinder
Hematology/Oncology Clinics of North America|August 9, 2005
AIDS-related primary central nervous system lymphomaYvette L Kasamon, Richard F Ambinder
Current Opinion in Oncology|February 7, 2013
Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradicationChristine M Durand, Richard F Ambinder
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
JCO Oncology Practice|March 6, 2020
A Tale of Two UrinesArjun Gupta, Richard F Ambinder
The Journal of Infectious Diseases|October 6, 2005
Mononucleosis in the laboratoryRichard F Ambinder, Lan Lin
Current Opinion in Oncology|August 23, 2002
Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirusHetty Carraway, Richard F Ambinder
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2018
Resistance Is Futile: Engineering the Adoptive T-Cell Therapies of the FutureEugene Shenderov, Richard F Ambinder
Current Treatment Options in Oncology|April 4, 2013
EBV-related lymphomas: new approaches to treatmentJennifer A Kanakry, Richard F Ambinder
Critical Reviews in Oncology/Hematology|November 21, 2007
Immunotherapies for Hodgkin's lymphomaYvette L Kasamon, Richard F Ambinder
Blood|June 4, 2011
When differentiation goes viralCourtney M Shirley, Richard F Ambinder
Blood|February 8, 2014
Old variables, new value: a refined IPI for DLBCLJennifer A Kanakry, Richard F Ambinder
Hematology/Oncology Clinics of North America|August 9, 2005
AIDS-related primary central nervous system lymphomaYvette L Kasamon, Richard F Ambinder
Current Opinion in Oncology|February 7, 2013
Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradicationChristine M Durand, Richard F Ambinder
Pageof 24